The technological base that supports the growth of the medical cannabis market
D9Tech establishes itself as the technological infrastructure driving the growth of the medical cannabis market in Brazil, offering integrated solutions in management, payments, and health with a focus on efficiency, security, and governance
As the medical cannabis market gains solidity and the regulatory debate advances, a silent technological transformation has been shaping the behind-the-scenes of this new scenario.
Far from the spotlight, D9Tech has established itself as the foundation that ensures efficiency, predictability, and security for the sustainable growth of the ecosystem in Brazil.
Founded in 2023, the Brazilian health-fintech has consolidated itself as an essential infrastructure for the sector. Its solutions have already supported the care of over 40,000 patients and account for 25% of the operations of medical cannabis importers in the country (RDC 660).
“We never sought noise. We seek real impact. Our role is to be the layer that ensures the sector operates with safety, efficiency, and governance,” emphasizes Gabriel Camargo, neuroscientist and CEO of D9Tech.
With impressive results, companies using D9Tech's solutions report gains of up to 80% in operational efficiency, significantly reducing errors, time, and costs, advancements that consolidate the company as a reference in technology and innovation applied to health.
Integrated solutions that connect the ecosystem
D9Tech offers a portfolio of solutions that meet the main demands of the medical cannabis chain:
D9Pro ERP: a complete management system, with automated workflows, a service center, integrated KYC, smart reports, document management, and logistical integration, all to optimize processes and ensure professionalism in operations.
D9Pag: proprietary payment solution, integrated with the ERP and the sector, with competitive rates and a focus on compliance, financial automation, and risk mitigation.
The company is also advancing towards the clinical end, with D9Med, a platform aimed at prescribing doctors, offering digital prescriptions, telemedicine, and smart tools for managing the therapeutic journey in a safe, intuitive, and integrated manner.
“At the beginning of the market, entrepreneurship was like building a house and still needing to make your own bricks. D9Tech emerges to change this scenario, delivering structured and connected blocks so that the sector can grow with efficiency and a focus on patient care,” explains Camargo.
Responsible innovation and future vision
As the sector moves towards a more regulated phase, D9Tech directs its efforts towards compliance infrastructure, pharmacovigilance, and applied intelligence, preparing for the ethical and strategic use of clinical data and artificial intelligence.
“The next era will be driven by intelligence and governance. Our role is to build this foundation with seriousness and responsibility,” reinforces the CEO.
Operating discreetly and consistently, D9Tech supports importers, associations, clinics, doctors, marketplaces, and compounding pharmacies, strengthening each link in the chain and promoting sustainable and professionalized growth for the sector.